Eric Poma
Chief Executive Officer at MOLECULAR TEMPLATES, INC.
Net worth: 41 456 $ as of 30/03/2024
Profile
Dr. Eric E.
Poma is a Director, Chief Executive & Scientific Officer at Molecular Templates, Inc. and a Chief Executive Officer & Director at Molecular Templates OpCo, Inc. He is on the Board of Directors at Molecular Templates, Inc. and Molecular Templates OpCo, Inc. Dr. Poma was previously employed as a Vice President-Business Development by Innovive Pharmaceuticals, Inc. and an Assistant Vice President-Business Development by ImClone LLC.
He received his undergraduate degree from the University of North Carolina at Chapel Hill, an MBA from The Leonard N Stern School of Business and a doctorate degree from the University of North Carolina at Chapel Hill.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 22/01/2024 | 18,507 ( 0.34% ) | 41 456 $ | 30/03/2024 |
Eric Poma active positions
| Companies | Position | Start |
|---|---|---|
| MOLECULAR TEMPLATES, INC. | Chief Executive Officer | 31/12/1999 |
Molecular Templates OpCo, Inc.
 Molecular Templates OpCo, Inc. Financial ConglomeratesFinance Molecular Templates OpCo, Inc. provides medical services. The company is headquartered in Austin, TX. | Chief Executive Officer | - |
Former positions of Eric Poma
| Companies | Position | End |
|---|---|---|
ImClone LLC
 ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | Corporate Officer/Principal | - |
Innovive Pharmaceuticals, Inc.
 Innovive Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology The Group's principal activity is developing compounds for the treatment of cancer. It currently have four products in development; INNO-406, tamibarotene, INNO-206 and INNO-406. The Group operates in the United States of America. | Corporate Officer/Principal | - |
Training of Eric Poma
| The Leonard N Stern School of Business | Masters Business Admin |
| University of North Carolina at Chapel Hill | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| MOLECULAR TEMPLATES, INC. | Health Technology |
| Private companies | 3 |
|---|---|
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | Health Technology |
Innovive Pharmaceuticals, Inc.
Innovive Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology The Group's principal activity is developing compounds for the treatment of cancer. It currently have four products in development; INNO-406, tamibarotene, INNO-206 and INNO-406. The Group operates in the United States of America. | Health Technology |
Molecular Templates OpCo, Inc.
Molecular Templates OpCo, Inc. Financial ConglomeratesFinance Molecular Templates OpCo, Inc. provides medical services. The company is headquartered in Austin, TX. | Finance |
- Stock Market
- Insiders
- Eric Poma
